Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
6,801	73.59296	1	male	1	25	25	ARF/MOSF w/Sepsis	ARF/MOSF	3	6	under $11k	44	72,719	45,524.3125	52,509.4688	29.5	black	29.796875	48	0.380981	0.261963	1	0	0	yes	0.25	0.4	no dnr	25	53	21.796875	67	28	35.5	null	2.199707	0.199982	0.699951	131	null	80	12	750	null	0	<2 mo. follow-up	0
6,802	77.73596	1	female	1	18	18	MOSF w/Malig	ARF/MOSF	1	null	under $11k	44	29,169	19,525.7812	25,135.4844	25.333328	black	22.699219	24	0.434998	0.315979	7	0	0	yes	0	0	dnr before sadm	-1	83	null	76	18	36.5	null	null	null	1.199951	135	null	86	6	5,050	null	5	<2 mo. follow-up	5
6,803	49.56897	1	male	1	27	27	Cirrhosis	COPD/CHF/Cirrhosis	1	null	under $11k	0	50,888	32,832.5938	40,125.4688	35.75	white	34.796875	54	0.565918	0.369995	1	0	0	no	0.75	0.3	dnr after sadm	21	74	9.099609	101	24	35.79688	null	4.5	1.799805	2	137	null	100	46	null	null	1	<2 mo. follow-up	1
6,804	62.05298	0	male	0	41	1,039	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	104,496	66,482.625	75,413.8125	52.25	white	27.5	69	0.764893	0.688965	1	0	0	no	0.5	0.5	no dnr	41	103	10.699219	68	14	36	247.59375	3.599609	0.799927	1.799805	138	7.40918	122	35	4,050	null	0	no(M2 and SIP pres)	0
6,805	63.51498	1	male	0	23	914	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	$25-$50k	9	85,938	57,368.0938	62,982.0312	13.666664	white	22.796875	37	0.740967	0.659912	18	0	0	no	1	1	no dnr	23	70	3.339844	150	22	36.5	303.3125	2.699707	0.699951	2.5	133	7.419922	205	39	2,520	0	0	no(M2 and SIP pres)	0
6,806	76.73096	1	male	0	11	157	COPD	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	11,799	7,380.9805	9,713.4375	11	white	16.199219	19	0.851929	0.756958	1	0	0	no	1	0.9	no dnr	11	114	5.5	119	41	40.29688	296.625	2.599609	1.5	1.899902	147	7.399414	216	27	4,517	0	0	no(M2 and SIP pres)	0
6,807	76.62695	1	female	1	26	26	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	89,138	56,273.4062	65,897.5625	33.25	white	26.296875	42	0.67395	0.578979	5	0	0	no	0.6	0.6	dnr after sadm	23	55	36.59375	190	24	36.39844	455.5	1.399902	0.899902	6.299805	125	7.40918	89	68	1,100	null	5	<2 mo. follow-up	5
6,808	75.53699	0	male	0	43	1,038	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	9	98,295	64,238.125	78,530.8125	42.75	white	34.398438	63	0.471985	0.353943	2	0	0	no	0.75	0.75	dnr after sadm	28	100	6.899414	110	24	36.89844	null	3.799805	0.299988	1	139	null	125	10	2,520	null	0	adl>=4 (>=5 if sur)	0
6,809	36.73898	0	female	0	11	1,036	CHF	COPD/CHF/Cirrhosis	1	14	null	0	28,019	17,699.375	20,122.5625	23.5	black	24.597656	37	0.85791	0.764893	10	0	0	no	0.75	0.75	no dnr	11	47	0.799927	124	36	35.79688	177.75	2.5	0.699951	2.099609	136	7.40918	99	54	1,280	0	0	no(M2 and SIP pres)	0
6,810	66.71594	0	male	0	21	1,037	CHF	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	52,966	32,957.3125	38,379.125	29	white	19.597656	22	0.860962	0.769897	1	0	0	no	0.95	0.9	no dnr	21	130	20.199219	156	40	36.09375	220.40625	2.099609	5.099609	1.299805	127	7.389648	57	26	1,525	4	1	no(M2 and SIP pres)	1
6,811	48.91699	0	female	0	6	1,037	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	$11-$25k	0	11,941	7,673.4336	8,605.97656	36	white	18.097656	23	0.907959	0.873901	1	0	0	no	0.9	0.95	no dnr	6	79	9.298828	118	24	36	404.75	3.699707	0.599976	2.199707	132	7.489258	110	55	1,645	1	null	no(M2 and SIP pres)	1.166748
6,812	80.73895	0	female	0	18	1,036	COPD	COPD/CHF/Cirrhosis	1	8	under $11k	0	26,876	16,527.1719	20,001.3438	20.666656	white	21.597656	21	0.751953	0.60791	1	0	0	no	0.75	0.75	dnr after sadm	14	81	0.049995	104	22	40	null	2.5	1.799805	1	132	null	254	13	4,725	0	0	no(M2 and SIP pres)	0
6,813	71.01996	1	female	1	3	3	MOSF w/Malig	ARF/MOSF	1	12	null	100	9,989	6,770.5664	8,636.40625	null	white	45.398438	70	0	0	7	0	0	metastatic	null	null	dnr before sadm	-1	70	13.199219	126	24	39.39844	null	2.5	0.5	0.899902	132	null	90	8	null	null	null	<2 mo. follow-up	4.333008
6,814	30.765	1	male	0	6	832	MOSF w/Malig	ARF/MOSF	0	null	null	0	19,435	13,216.4766	20,892.7656	6	white	23.898438	31	0.685913	0.593994	7	0	0	yes	0.98	0.9	no dnr	6	83	10.599609	135	20	35.89844	476	3.899902	0.399963	1.299805	139	7.399414	404	22	3,800	null	null	null	2.511231
6,815	41.95999	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	0	27,633	0	0	63	white	43.195313	100	0.492981	0.375977	2	0	0	no	0.01	0.000001	dnr after sadm	5	76	7.899414	124	24	36.39844	167.34375	2.399902	6	3	133	7.359375	173	70	638	null	0	<2 mo. follow-up	0
6,816	79.258	1	male	0	10	37	Lung Cancer	Cancer	1	12	under $11k	26	8,220	6,202.9141	7,946.50781	10	black	16.5	16	0.575928	0.254944	1	0	0	metastatic	0.2	0	dnr after sadm	1	107	19.097656	107	24	36.59375	165.28125	2.299805	2	7.399414	135	7.319336	242	80	790	null	5	<2 mo. follow-up	5
6,817	79.159	1	male	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	5	15	under $11k	61	16,072	10,463.8125	12,797.9375	27.333328	black	36.296875	69	0.159973	0.078995	1	1	1	no	0.5	0.1	dnr after sadm	3	75	5.299805	104	40	38.29688	283.3125	2.5	1	0.799927	143	7.399414	97	7	4,550	null	7	<2 mo. follow-up	7
6,818	70.38495	1	male	1	4	4	Lung Cancer	Cancer	3	10	under $11k	9	4,010	2,658.7598	3,309.26953	22	white	41.59375	37	0.046997	0.001	1	1	0	metastatic	0.1	0	dnr after sadm	2	74	41.398438	107	8	37.79688	247.5	2.299805	5.5	4.5	146	7.359375	233	147	1,955	null	null	<2 mo. follow-up	3.628906
6,819	91.86597	1	female	1	6	6	Coma	Coma	0	6	under $11k	89	9,946	6,350.8555	7,375.4375	36	white	36.695313	69	0	0	1	0	0	no	0	0	dnr after sadm	3	67	6.5	93	20	37.5	null	2.199707	1.199951	3.599609	140	null	75	49	null	null	1	<2 mo. follow-up	1
6,820	71.81396	1	female	0	20	845	ARF/MOSF w/Sepsis	ARF/MOSF	4	10	$11-$25k	0	34,771	19,316.3281	22,610.3281	35.333313	white	25.898438	55	0.751953	0.672974	1	1	0	no	0.8	0.6	no dnr	20	69	7.199219	107	24	37.79688	null	null	0.399963	0.799927	140	null	146	13	425	null	6	adl>=4 (>=5 if sur)	6
6,821	66.09998	1	female	1	34	34	Cirrhosis	COPD/CHF/Cirrhosis	4	10	under $11k	0	118,170	75,117.25	92,485.625	52.75	white	34.195313	84	0.409973	0.210999	1	1	0	no	0.25	0.15	dnr after sadm	34	62	3.699707	106	27	38	null	2.599609	38.898438	1.199951	126	null	86	29	1,465	null	0	<2 mo. follow-up	0
6,822	42.31598	0	male	0	10	1,030	ARF/MOSF w/Sepsis	ARF/MOSF	0	0	under $11k	26	16,046	10,801.6797	12,408.9688	34	white	19.5	14	0.870972	0.824951	1	0	0	no	0.9	0.9	no dnr	10	119	10.298828	114	32	36.19531	232.625	4.099609	0.199982	1.099854	138	7.419922	182	19	2,020	null	0	adl>=4 (>=5 if sur)	0
6,823	45.05698	0	male	0	26	1,027	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	9	48,690	32,809.0625	37,353.625	14.75	white	21.699219	34	0.844971	0.791992	5	0	0	no	0.95	0.95	no dnr	26	99	25.699219	107	24	36.39844	228.5625	2.599609	1.199951	0.699951	135	7.399414	84	15	1,200	0	0	no(M2 and SIP pres)	0
6,824	73.49194	0	male	0	6	1,027	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	6,658	3,897.0918	5,010.66797	7	white	16.398438	35	0.873901	0.790894	1	0	0	no	0.8	0.7	no dnr	6	71	18.898438	126	24	39	268	2.799805	1	1.099854	131	7.579102	107	13	4,010	5	4	no(M2 and SIP pres)	4
6,825	63.23599	1	male	1	33	33	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	101,217	64,560.5625	77,224.375	53.75	white	27.398438	60	0.690918	0.598999	12	0	0	no	0.6	0.6	dnr after sadm	33	100	11.699219	82	20	36.19531	224	3.699707	1	0.899902	138	7.369141	175	17	1,550	null	2	<2 mo. follow-up	2
6,826	38.59799	1	male	0	7	187	Cirrhosis	COPD/CHF/Cirrhosis	2	11	under $11k	0	8,412	5,658.4922	5,928.22656	6.5	white	20	26	0.883911	0.806885	1	0	0	no	0.65	0.5	no dnr	7	102	10.599609	77	30	38.29688	null	3.099609	1.599854	1.099854	139	null	86	19	3,100	null	null	no(M2 and SIP pres)	3.171387
6,827	66.05597	1	male	0	12	32	MOSF w/Malig	ARF/MOSF	1	10	$11-$25k	26	11,636	8,340.9766	10,750.9297	12.5	white	28	50	0.396973	0.277954	1	0	0	metastatic	0.7	0.6	dnr after sadm	1	83	7.599609	123	28	38.39844	265.6875	1.699951	1.099854	2.5	135	7.429688	132	51	2,523	null	6	<2 mo. follow-up	6
6,828	68.59399	1	male	0	20	758	Cirrhosis	COPD/CHF/Cirrhosis	4	7	under $11k	0	24,108	16,869.2656	20,222.0781	13.333328	black	18.898438	19	0.756958	0.615967	1	0	0	no	0.95	0.9	no dnr	20	123	9.699219	70	20	35.79688	null	null	null	2.099609	133	7.449219	116	41	1,750	0	1	null	1
6,829	78.05298	0	male	0	7	1,025	COPD	COPD/CHF/Cirrhosis	4	null	null	9	6,979	4,518.457	5,866.95703	7	white	17.296875	45	0.810913	0.69397	1	0	0	no	1	0.9	no dnr	7	111	9.398438	120	10	36	217.5	1.699951	3.799805	3.799805	138	7.359375	80	55	435	7	5	adl>=4 (>=5 if sur)	5
6,830	67.86896	1	male	0	16	87	Lung Cancer	Cancer	4	10	under $11k	0	14,776	10,952.4766	13,473.75	13	black	23.199219	23	0.555908	0.233978	1	1	0	metastatic	0.9	0.75	no dnr	16	77	7.899414	110	24	36.19531	null	3	1.5	0.899902	131	null	220	11	1,350	5	null	no(M2 and SIP pres)	3.854981
6,831	65.24298	1	male	0	9	31	Lung Cancer	Cancer	6	12	$11-$25k	0	12,269	8,320.5469	9,107.85938	7.5	white	17.699219	28	0.69397	0.403992	1	0	0	metastatic	0.1	0.02	dnr after sadm	5	103	4.799805	65	22	37.29688	null	2.899902	0.5	3.699707	132	null	101	50	4,700	3	1	<2 mo. follow-up	1
6,832	94.70996	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	0	4	under $11k	41	8,346	4,438.5547	5,558.12891	29	black	27.699219	41	0.396973	0.277954	1	0	0	no	null	null	no dnr	4	61	17.296875	115	14	38.69531	180	2	11.898438	2.299805	157	7.459961	368	72	2,645	null	5	<2 mo. follow-up	5
6,833	45.57999	1	female	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	>$50k	0	30,749	19,384.8438	23,149.7812	70	white	31.597656	40	0.760986	0.684937	1	0	0	no	0.95	0.95	dnr after sadm	9	121	22.699219	136	27	39	232.5	3.199707	0.599976	1.099854	136	7.469727	128	10	2,600	null	0	<2 mo. follow-up	0
6,834	63.16199	1	female	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	under $11k	55	65,833	42,372.0938	52,720.125	50	white	37.898438	65	0.161987	0.080994	8	0	0	no	0.8	0.7	dnr after sadm	10	118	8.099609	64	12	38.69531	187.5	2	8	0.799927	136	7.419922	79	12	4,825	null	0	<2 mo. follow-up	0
6,835	66.08899	1	female	0	45	154	MOSF w/Malig	ARF/MOSF	1	11	$11-$25k	0	73,540	50,863.8125	54,533.7188	35	white	26.699219	37	0.496948	0.379944	5	0	0	metastatic	0.9	0.8	no dnr	45	79	8.298828	110	24	35.79688	204.75	3.599609	1.299805	0.599976	139	7.419922	262	8	null	0	0	SIP>=30	0
6,836	65.86395	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	$11-$25k	41	20,931	10,538.9219	13,591.3672	38	white	38.59375	51	0.21698	0.119995	4	0	0	no	0.5	0.25	no dnr	8	139	17.296875	124	38	36	182.84375	4.099609	0.799927	0.899902	142	7.509766	151	19	null	null	0	<2 mo. follow-up	0
6,837	51.96198	0	male	0	5	1,019	Colon Cancer	Cancer	1	13	$25-$50k	0	13,199	8,313.1406	9,304.17969	17	white	12.798828	10	0.882935	0.734985	1	0	0	metastatic	0.85	0.85	no dnr	5	72	5.899414	65	28	35.39844	null	3.399902	1	1.399902	137	7.5	95	29	600	0	0	no(M2 and SIP pres)	0
6,838	78.71295	1	female	0	14	61	Lung Cancer	Cancer	4	null	under $11k	0	10,003	7,692.2266	10,223.0234	7	white	15.199219	34	0.710938	0.429993	1	0	0	metastatic	0.5	0.1	dnr before sadm	-1	72	13.798828	110	32	38.09375	304	null	0.199982	7	173	7.339844	98	148	525	0	null	null	0.494751
6,839	77.87	1	female	0	34	232	ARF/MOSF w/Sepsis	ARF/MOSF	1	0	under $11k	0	59,632	37,024.9688	45,438.25	33.25	black	34.195313	52	0.487976	0.369995	3	0	0	no	0.05	0.000125	no dnr	34	72	22.5	167	12	37.09375	336.625	1.899902	5.099609	1.399902	118	7.489258	219	57	842	null	0	adl>=4 (>=5 if sur)	0
6,840	56.86499	1	male	1	13	13	Coma	Coma	2	16	$25-$50k	100	30,854	16,650.0625	20,634.2188	28.5	black	25	67	0.199982	0.139984	4	1	0	no	0.05	0.03	dnr after sadm	11	61	6.799805	94	8	36.5	336.625	2.399902	0.5	0.799927	137	7.469727	160	15	1,855	null	1	<2 mo. follow-up	1
6,841	23.68799	0	male	0	7	1,018	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	under $11k	9	32,150	21,773.7969	24,667.1562	5.5	black	27	24	0.831909	0.774902	9	0	0	no	null	null	no dnr	7	68	11.099609	103	36	36.19531	293.3125	2.299805	3.699707	1.299805	136	7.429688	277	23	2,470	null	null	null	2.947266
6,842	48.98798	1	female	0	21	501	MOSF w/Malig	ARF/MOSF	2	11	$25-$50k	0	41,310	27,047.2812	32,100.8281	37.666657	white	31.796875	48	0.425964	0.306946	2	0	0	metastatic	0.5	0.5	no dnr	21	123	23	136	26	36.39844	310	2.699707	1	3.299805	142	7.459961	230	54	1,546	null	2	no(M2 and SIP pres)	2
6,843	19.70999	1	male	0	26	303	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	under $11k	0	62,643	40,415.6875	47,093.0938	25.5	black	27.699219	38	0.866943	0.819946	4	0	0	no	0.5	0.4	no dnr	26	57	5	129	12	39.39844	108.32812	2.5	2.299805	0.799927	131	7.459961	91	6	3,275	null	7	null	7
6,844	62.75198	0	female	0	38	1,016	Coma	Coma	0	12	null	61	75,458	48,957.2188	56,833.6875	30	white	17.199219	25	0.613892	0.550903	1	0	0	no	0.8	0.8	no dnr	38	50	7.099609	50	10	34.09375	380.9375	2.5	0.5	1.5	150	7.399414	47	33	2,535	null	0	no(M2 and SIP pres)	0
6,845	56.71698	1	male	0	52	437	Coma	Coma	1	null	null	100	71,283	46,700.2812	54,950.3125	30.5	white	24.597656	38	0.269958	0.201996	1	0	0	no	0.2	0.1	dnr after sadm	28	96	1.199951	69	20	36.29688	null	3.299805	0.299988	0.899902	142	null	170	10	2,750	null	null	null	3.061035
6,846	59.79498	0	female	0	6	1,012	COPD	COPD/CHF/Cirrhosis	4	10	under $11k	0	5,397	3,738.9668	4,557.79688	12	white	12.298828	20	0.920898	0.865967	1	0	0	yes	0.95	0.95	no dnr	6	71	0.299988	114	20	36.89844	null	3.799805	1	1.699951	133	null	188	21	2,575	1	4	no(M2 and SIP pres)	4
6,847	85.284	1	female	0	11	42	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	9	16,843	10,260.3906	11,922.4453	21	white	30.097656	47	0.469971	0.35199	1	0	0	yes	0.9	0.75	dnr after sadm	8	73	40.695313	77	38	35.69531	104	2	0.599976	2.699707	141	7.5	152	59	319	2	1	<2 mo. follow-up	1
6,848	77.85596	1	female	1	7	7	CHF	COPD/CHF/Cirrhosis	2	7	under $11k	0	6,140	4,446.1875	5,399.77734	23	black	15.298828	19	0.802979	0.681885	1	0	0	metastatic	0.7	0.6	dnr after sadm	7	64	12.298828	120	37	39.09375	160	2.5	0.699951	1.599854	132	7.429688	114	22	1,810	0	0	<2 mo. follow-up	0
6,849	67.08295	0	male	0	48	1,009	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	0	88,688	58,003.0625	67,012	38.75	white	15.099609	23	0.897949	0.860962	1	1	0	no	0.75	0.75	no dnr	48	117	9.398438	77	36	36.39844	null	null	null	0.799927	126	null	112	16	1,850	0	1	no(M2 and SIP pres)	1
6,850	67.836	0	male	0	16	1,008	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	9	31,353	21,080.125	24,101.3438	22.666656	white	26.097656	38	0.696899	0.605957	4	0	0	no	0.95	0.9	no dnr	16	74	17.296875	65	36	37.69531	108.32812	2.399902	9.699219	1.299805	129	7.469727	74	32	2,419	0	0	SIP>=30	0
6,851	78.05597	1	female	0	45	195	ARF/MOSF w/Sepsis	ARF/MOSF	2	5	under $11k	0	100,750	63,637.6562	76,393.9375	36.75	black	25.597656	36	0.730957	0.647949	1	0	0	no	0.5	0.4	no dnr	45	69	9.5	189	10	38.5	146	1.399902	2	1.799805	147	7.599609	208	37	2,517	null	4	adl>=4 (>=5 if sur)	4
6,852	71.95599	0	female	0	13	1,008	CHF	COPD/CHF/Cirrhosis	3	11	under $11k	0	9,569	7,085.5625	7,397.41797	9	white	26.296875	36	0.691895	0.525879	1	1	0	yes	0.9	0.8	no dnr	13	113	12.599609	63	36	35.89844	286.625	2.399902	2.599609	1.299805	136	7.40918	152	29	2,150	1	0	no(M2 and SIP pres)	0
6,853	65.88599	1	female	1	18	18	MOSF w/Malig	ARF/MOSF	1	9	under $11k	9	null	null	null	35.333313	black	34.195313	70	0.272949	0.164978	2	0	0	metastatic	0.3	0.1	null	null	77	14	104	20	36.09375	203.3125	4.199219	0.399963	1.099854	142	7.449219	145	21	3,090	1	0	<2 mo. follow-up	0
6,854	57.13898	1	female	1	35	35	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	124,947	80,193.3125	92,762.125	49.25	white	27.597656	73	0.733887	0.650879	6	1	0	no	0.5	0.5	no dnr	35	120	16	48	10	35.29688	188	1.899902	0.699951	0.699951	134	7.509766	138	17	2,713	null	6	<2 mo. follow-up	6
6,855	67.68195	1	female	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	under $11k	9	54,893	33,656.0312	39,587.3438	48	black	35.296875	79	0.44696	0.327942	6	1	0	no	0.5	0.5	dnr after sadm	8	53	17	120	26	38.79688	230	2.599609	5.399414	1.599854	155	7.449219	143	46	2,690	null	0	<2 mo. follow-up	0
6,856	63.814	1	male	0	6	92	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$25-$50k	9	19,911	12,975.0781	15,298.0156	34	white	24.699219	39	0.741943	0.660889	4	1	0	no	0.95	0.9	no dnr	6	134	8.298828	129	8	38	193.3125	2.799805	1.699951	0.899902	147	7.5	62	11	7,220	1	0	null	0
6,857	87.29095	1	female	0	11	23	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	41	19,740	12,731.9453	14,307.5	21.5	white	23.199219	35	0.574951	0.463989	1	0	1	no	0.4	0.35	dnr after sadm	4	74	10.599609	116	16	36.19531	428	3.799805	1	1.399902	141	7.479492	74	23	4,760	null	4	<2 mo. follow-up	4
6,858	67.29895	1	male	0	54	706	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	37	173,938	115,405.938	130,774.312	46	white	29.199219	48	0.43396	0.314941	29	0	0	no	0.85	0.75	no dnr	54	130	10.898438	71	32	38	202.5	3	0.699951	1.399902	143	7.469727	162	10	1,305	null	2	no(M2 and SIP pres)	2
6,859	53.88898	0	female	0	28	1,002	Coma	Coma	2	12	under $11k	94	46,212	31,023.3125	34,375.7812	26.75	white	24	53	0.179993	0.122986	1	1	0	metastatic	0.1	0.05	dnr after sadm	8	116	10.5	72	8	36.59375	195	2.699707	1.199951	1.299805	139	7.389648	137	22	1,760	null	6	SIP>=30	6
6,860	51.43298	0	female	0	6	1,002	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	8,304	4,943.8906	5,949.29688	21	black	21.597656	22	0.872925	0.828979	1	0	0	no	1	1	no dnr	6	31	18.597656	63	36	36.29688	122.5	2.199707	2	0.899902	138	7.459961	107	20	2,030	0	0	no(M2 and SIP pres)	0
6,861	74.47498	1	male	0	3	265	Lung Cancer	Cancer	1	12	$11-$25k	0	2,994	2,017.0703	2,427.87891	null	white	19.5	20	0.629883	0.317993	1	0	0	metastatic	0.8	0.6	no dnr	3	69	42.59375	101	24	37.89844	null	4.099609	1.399902	1.5	128	null	99	30	2,200	0	0	no(M2 and SIP pres)	0
6,862	51.41699	0	female	0	10	1,000	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	null	0	15,681	10,553.5234	12,059.9141	19.5	black	21.699219	42	0.871948	0.827881	1	0	0	no	0.95	0.85	no dnr	10	56	17	129	24	38.19531	72	2.5	5.5	5	146	7.289062	37	40	207	0	0	no(M2 and SIP pres)	0
6,863	63.258	0	male	0	5	1,000	COPD	COPD/CHF/Cirrhosis	5	11	under $11k	0	8,534	4,432.4023	5,277.58984	19	white	19.199219	32	0.879883	0.799927	1	1	0	no	0.75	0.75	no dnr	5	68	4.799805	71	24	36.39844	240	3.299805	0.5	0.899902	137	7.349609	97	12	null	0	0	no(M2 and SIP pres)	0
6,864	66.00098	0	male	0	4	1,000	CHF	COPD/CHF/Cirrhosis	1	12	under $11k	0	12,022	6,259.5586	8,188.11719	8	black	17	4	0.86792	0.780884	4	0	0	no	0.99	0.95	no dnr	4	75	28.796875	96	24	35.39844	77.54688	1.799805	0.699951	4.799805	145	7.449219	322	158	1,430	0	0	no(M2 and SIP pres)	0
6,865	56.88397	1	male	0	7	24	Lung Cancer	Cancer	1	14	>$50k	9	4,245	3,281.3887	4,371.34766	4	white	39.296875	39	0.107986	0.004	1	0	0	metastatic	0	0	dnr after sadm	2	85	3.599609	135	30	35.59375	112.23438	2.5	0.199982	1.199951	147	7.229492	180	27	1,300	null	0	<2 mo. follow-up	0
6,866	51.55399	0	female	0	27	998	COPD	COPD/CHF/Cirrhosis	3	11	under $11k	0	31,701	21,109.5625	25,046.2188	12.5	white	23.699219	36	0.883911	0.806885	1	0	0	no	0.7	0.5	no dnr	27	147	16.199219	153	28	38	93.32812	4.599609	1.299805	1.899902	129	7.5	254	33	1,495	0	null	no(M2 and SIP pres)	0.494751
6,867	77.96594	1	female	1	11	11	Coma	Coma	0	12	under $11k	94	53,921	36,673.3438	43,470	31	white	17.796875	20	0.167999	0.112991	21	0	0	no	0.1	0	dnr after sadm	6	67	11.099609	147	38	38.19531	180	2.099609	0.599976	1.399902	134	7.40918	278	28	1,310	null	1	<2 mo. follow-up	1
6,868	41.405	0	male	0	14	998	Cirrhosis	COPD/CHF/Cirrhosis	3	12	under $11k	0	11,648	8,647.1719	10,721.7656	5.666664	white	24.097656	18	0.829956	0.721924	1	0	0	no	1	1	no dnr	14	47	18.398438	150	34	39.5	306	1.399902	2.199707	1.5	146	7.379883	373	42	2,545	3	2	no(M2 and SIP pres)	2
6,869	59.41699	0	male	0	6	997	CHF	COPD/CHF/Cirrhosis	3	9	under $11k	0	3,689	2,812.7773	2,914.51953	4	hispanic	14.5	13	0.918945	0.862915	1	1	0	no	0.95	0.85	no dnr	6	135	19.898438	111	7	38.39844	340	3.299805	0.899902	0.799927	136	7.449219	138	5	3,625	4	null	SIP>=30	3.183106
6,870	78.76196	1	female	0	13	164	Coma	Coma	4	8	under $11k	26	34,205	18,992.0469	23,174.4688	21	white	23.597656	41	0.362976	0.28894	8	1	0	no	0.6	0.5	no dnr	13	60	12.5	124	32	38.69531	245.6875	null	null	0.899902	137	7.429688	164	20	1,800	null	0	adl>=4 (>=5 if sur)	0
6,871	70.04199	1	female	0	17	92	MOSF w/Malig	ARF/MOSF	4	8	under $11k	0	30,676	21,929.1094	27,445.9844	17	white	35.5	53	0.201996	0.108994	11	0	0	metastatic	0.1	0	dnr before sadm	-9	77	9.798828	70	12	36.19531	404.75	4	0.5	1.799805	140	7.549805	83	22	900	1	0	adl>=4 (>=5 if sur)	0
6,872	57.366	1	female	0	10	156	Lung Cancer	Cancer	1	11	$11-$25k	0	10,310	7,487.3047	9,577.3125	11	black	8.699219	5	0.848999	0.667969	1	0	0	metastatic	0.8	0.5	no dnr	10	143	26.398438	118	30	37	278	2.399902	1.199951	1.899902	154	7.429688	256	47	3,655	0	null	null	0.494751
6,873	70.69098	1	male	1	24	24	MOSF w/Malig	ARF/MOSF	2	12	null	0	29,236	20,551.6562	27,707.2812	26	white	29.898438	35	0.404968	0.28595	4	0	0	metastatic	0.5	0.2	dnr after sadm	6	71	5	108	20	37.5	null	2.699707	2.399902	1.299805	132	null	134	35	null	null	0	<2 mo. follow-up	0
6,874	70.17395	0	female	0	4	996	CHF	COPD/CHF/Cirrhosis	5	12	under $11k	0	3,382	2,383.6094	2,952.89844	5	white	15.398438	33	0.890991	0.817993	1	1	0	no	0.8	0.8	no dnr	4	67	2.699707	100	28	36.59375	371.375	null	0.899902	2	147	7.489258	254	78	2,375	0	null	no(M2 and SIP pres)	0.494751
6,875	37.71899	0	male	0	4	994	Cirrhosis	COPD/CHF/Cirrhosis	3	12	under $11k	0	4,348	2,924.3496	3,215.39844	7	black	16.898438	22	0.910889	0.848999	1	0	0	no	0.95	0.85	no dnr	4	114	5.599609	79	20	36.5	null	2.599609	5.099609	1	133	null	112	7	null	0	1	no(M2 and SIP pres)	1
6,876	29.33099	1	female	1	36	36	MOSF w/Malig	ARF/MOSF	2	15	under $11k	0	94,641	60,107.875	70,521.5	49.75	white	30.296875	50	0.567993	0.45697	3	0	0	yes	0.5	0.5	no dnr	36	64	11.099609	110	28	36.69531	209.5	4.099609	0.599976	1.099854	142	7.389648	176	22	1,500	null	2	<2 mo. follow-up	2
6,877	63.10199	1	male	1	24	24	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	101,785	null	null	54.666657	hispanic	30.296875	56	0.66394	0.566895	4	0	0	no	0.5	0.5	dnr after sadm	18	107	11.099609	107	28	35.39844	null	3.299805	0.299988	1.199951	147	null	161	7	1,200	null	0	<2 mo. follow-up	0
6,878	47.97299	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	null	41	34,317	21,957.0469	26,373.5469	50	white	54.796875	95	0.014	0.003	6	0	0	no	0	0	dnr after sadm	3	68	11.099609	77	22	36	null	4.099609	1	1.199951	122	null	1,051	22	1,450	null	0	<2 mo. follow-up	0
6,879	63.10199	1	male	1	8	8	CHF	COPD/CHF/Cirrhosis	5	null	null	94	45,091	24,652.875	29,997.6562	63	white	33.09375	62	0.161987	0.042	3	1	0	no	0.05	0	no dnr	8	97	4.299805	50	16	35.79688	238.09375	3.099609	0.299988	2.5	146	7.289062	64	71	1,535	null	0	<2 mo. follow-up	0
6,880	67.64697	1	female	0	22	234	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	under $11k	0	39,043	25,974.0781	28,633.7188	40	white	30.597656	44	0.549927	0.435974	5	1	0	yes	0.8	0.7	no dnr	22	100	11.099609	151	11	39	80	2	0.5	0.599976	147	7.40918	77	7	2,000	null	1	null	1
6,881	91.69598	0	male	0	15	989	COPD	COPD/CHF/Cirrhosis	1	1	under $11k	26	29,155	19,497.1406	23,714.0781	12.333328	black	21.097656	19	0.447998	0.246979	15	0	0	no	0.7	0.5	dnr after sadm	1	61	24.398438	99	10	38.29688	148.3125	2.099609	40.09375	0.899902	158	7.419922	135	54	433	null	2	adl>=4 (>=5 if sur)	2
6,882	68.24597	1	male	1	18	18	MOSF w/Malig	ARF/MOSF	2	12	$11-$25k	0	23,307	16,309.6172	22,747.5625	16.333328	white	30.699219	48	0.532959	0.418945	1	0	0	yes	null	null	dnr after sadm	7	63	30.097656	118	22	37.29688	310	1.199951	0.5	0.5	127	7.429688	115	8	1,980	0	3	<2 mo. follow-up	3
6,883	43.754	1	female	1	4	4	Lung Cancer	Cancer	1	2	under $11k	0	3,065	2,168.3652	2,810.16992	14	black	47.796875	67	0.031998	0	1	0	0	metastatic	0	0	dnr after sadm	3	47	15.099609	150	30	36.59375	177.53125	2.899902	2.799805	1.299805	154	7.369141	192	36	1,670	7	5	<2 mo. follow-up	5
6,884	54.08398	1	female	1	23	23	Coma	Coma	0	18	$25-$50k	9	43,798	28,933.9219	34,577.9688	29.666656	white	17.199219	25	0.834961	0.80188	1	0	0	no	0.6	0.5	dnr after sadm	12	76	8.298828	70	20	35.89844	null	3.699707	0.399963	1.099854	139	null	98	11	3,850	null	0	<2 mo. follow-up	0
6,885	74.02899	1	female	1	16	16	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$11-$25k	44	45,086	28,275.7812	32,509.125	42	white	29.398438	62	0.474976	0.356995	1	1	0	no	0.8	0.5	no dnr	16	59	18.097656	77	28	36.09375	null	3.899902	0.599976	0.699951	141	null	115	4	590	null	0	<2 mo. follow-up	0
6,886	52.93399	0	male	0	7	986	COPD	COPD/CHF/Cirrhosis	5	12	under $11k	0	7,492	5,008.3906	5,883.04688	8.5	white	31.296875	36	0.786987	0.657959	1	1	0	no	0.8	0.75	no dnr	7	61	18.398438	124	9	36.69531	133.3125	3	1.899902	8.898438	154	7.479492	165	111	744	0	3	no(M2 and SIP pres)	3
6,887	69.74896	0	female	0	13	988	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	0	17,451	11,142.8672	12,898.125	21	white	24	23	0.787964	0.659912	1	0	0	no	0.5	0.3	dnr after sadm	2	120	27.699219	106	40	38.09375	null	3.299805	1.199951	10.298828	135	7.389648	254	83	0	6	5	adl>=4 (>=5 if sur)	5
6,888	78.17896	1	female	1	46	46	ARF/MOSF w/Sepsis	ARF/MOSF	5	12	null	9	118,516	75,014.6875	86,490	53.25	white	44.5	89	0.188995	0.099991	1	1	0	no	0.2	0.05	dnr after sadm	16	45	18.296875	100	20	37.59375	300	null	null	0.899902	138	7.399414	100	15	1,355	null	7	<2 mo. follow-up	7
6,889	45.862	0	male	0	25	985	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	64,846	42,125.4688	48,898.6875	36.5	white	30.597656	40	0.73999	0.658936	4	0	0	no	0.5	0.5	no dnr	25	60	4.399414	113	14	36.69531	88.875	1.899902	0.399963	0.599976	135	7.459961	388	10	5,840	null	null	null	2.752441
6,890	68.77795	1	male	0	18	34	Cirrhosis	COPD/CHF/Cirrhosis	4	11	under $11k	9	16,177	11,637.75	12,156.0078	12.666664	white	18.898438	26	0.728882	0.575928	1	0	0	no	0.05	0.02	dnr after sadm	2	64	6.299805	120	42	39.09375	257.125	2.699707	0.899902	0.299988	132	7.55957	135	2	2,415	null	5	<2 mo. follow-up	5
6,891	49.41498	1	male	1	146	146	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	26	380,612	250,155	307,091.75	51.25	white	31.699219	65	0.572998	0.461975	8	0	0	no	0.7	0.9	dnr after sadm	145	116	10.099609	74	12	40	330	3	0.699951	1.099854	131	7.479492	117	13	2,240	null	2	adl>=4 (>=5 if sur)	2
6,892	33.19897	0	male	0	8	984	ARF/MOSF w/Sepsis	ARF/MOSF	4	11	$11-$25k	0	12,548	8,606.9453	10,165.5156	16.5	hispanic	26.296875	52	0.869995	0.823975	1	1	0	no	0.5	0.5	no dnr	8	128	19	116	40	37.69531	206.65625	2.599609	0.699951	0.599976	142	7.439453	192	22	2,370	0	4	SIP>=30	4
6,893	61.314	1	female	0	5	47	Lung Cancer	Cancer	3	9	null	0	4,206	3,020.4023	3,990.21875	8	white	26.398438	18	0.487976	0.168976	1	0	0	metastatic	0.3	0	dnr after sadm	2	109	9.099609	78	24	37.09375	216	3.699707	0.5	0.899902	141	7.369141	146	30	null	0	null	<2 mo. follow-up	0.494751
6,894	53.71399	1	female	0	7	80	Lung Cancer	Cancer	3	7	under $11k	0	6,541	4,582.8438	5,900.66797	3.5	white	28.796875	18	0.444946	0.134979	1	0	0	metastatic	0.2	0	dnr after sadm	1	68	22.199219	65	12	35.59375	158	3.599609	0.5	3.899902	136	7.329102	210	148	1,325	3	5	SIP>=30	5
6,895	57.383	1	female	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	null	41	80,893	51,551.375	61,187.25	40.5	white	29.296875	46	0.514893	0.398987	8	0	0	no	0.1	0.05	dnr after sadm	9	63	null	60	24	36	292.5625	3.799805	0.799927	1.299805	142	7.429688	103	29	null	null	4	<2 mo. follow-up	4
6,896	66.88599	0	female	0	7	982	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$25-$50k	41	11,154	7,366.8008	9,033.42969	21.5	white	14.599609	19	0.830933	0.772949	1	1	0	no	1	0.95	no dnr	7	64	6.099609	75	9	37.79688	280	3.199707	1.099854	1.399902	137	7.489258	168	30	1,698	null	0	null	0
6,897	78.00098	1	male	0	10	248	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	0	15,832	9,529.125	11,788.2578	13.5	white	15.099609	32	0.85791	0.765991	1	0	0	no	0.9	0.95	no dnr	10	69	13	126	28	37.79688	151	2.199707	0.5	0.899902	146	7.489258	95	13	1,315	1	1	null	1
6,898	79.02295	1	male	0	24	26	MOSF w/Malig	ARF/MOSF	4	12	$11-$25k	0	35,428	24,418.9062	30,912.5781	32.333313	white	37.5	52	0.227997	0.127991	7	0	0	yes	0.15	0	dnr before sadm	-5	63	9.398438	116	10	38.19531	125	3.699707	1	0.699951	147	7.419922	147	20	760	null	5	<2 mo. follow-up	5
6,899	40.961	0	female	0	43	978	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	null	0	93,065	60,890.4062	72,025.5625	41.5	white	29.898438	56	0.804932	0.73999	1	0	0	no	0.6	0.6	no dnr	43	131	8.898438	77	22	36.29688	163.25	2.899902	0.399963	5.399414	135	7.359375	374	82	2,250	null	0	no(M2 and SIP pres)	0
6,900	55.96198	1	female	0	5	386	CHF	COPD/CHF/Cirrhosis	3	7	null	0	3,799	2,804.1816	2,853.17969	10	white	19.199219	25	0.891968	0.819946	1	1	0	no	0.8	0.7	no dnr	5	120	0.799927	119	40	35.39844	null	null	null	1.5	142	null	314	23	605	0	3	no(M2 and SIP pres)	3

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.